Shaolin Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Shaolin Capital Management’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-359,721	Closed	-$3.69M	–	919
2023 Q2	$3.69M	Sell	359,721 -12,915	-3%	-$132K	0.12%	124
2023 Q1	$3.77M	Sell	372,636 -2,364	-0.6%	-$23.8K	0.11%	165
2022 Q4	$3.75M	Buy	375,000 +150,000	+67%	+$1.48M	0.11%	237
2022 Q3	$2.19M	Hold	225,000	–	–	0.06%	348
2022 Q2	$2.18M	Buy	225,000 +47,223	+27%	+$459K	0.05%	389
2022 Q1	$1.73M	Buy	+177,777	New	+$1.72M	0.04%	424

Shaolin Capital Management's DALS Position: Q3 2023 in Review

Shaolin Capital Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 359,721 shares — an estimated $3.69M sold.

Shaolin Capital Management first reported a position in DALS in Q1 2022 and held it in 6 quarters. The position peaked at $3.77M in Q1 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Shaolin Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Shaolin Capital Management sold 359,721 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $3.69M.
Shaolin Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 6 quarters.
Shaolin Capital Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $3.77M in Q1 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Shaolin Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.